These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 23475077)

  • 1. Peritubular capillary rarefaction: a new therapeutic target in chronic kidney disease.
    Kida Y; Tchao BN; Yamaguchi I
    Pediatr Nephrol; 2014 Mar; 29(3):333-42. PubMed ID: 23475077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritubular Capillary Rarefaction: An Underappreciated Regulator of CKD Progression.
    Kida Y
    Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RAS protein activator-like 2 (RASAL2) initiates peritubular capillary rarefaction in hypoxic renal interstitial fibrosis.
    Zhang Y; Yang Y; Hu X; Wei B; Shen Q; Shi C; Chen P
    Transl Res; 2024 Jul; 269():14-30. PubMed ID: 38453052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial sirtuin 1 inactivation enhances capillary rarefaction and fibrosis following kidney injury through Notch activation.
    Kida Y; Zullo JA; Goligorsky MS
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1074-9. PubMed ID: 27524235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tubular atrophy in the pathogenesis of chronic kidney disease progression.
    Schelling JR
    Pediatr Nephrol; 2016 May; 31(5):693-706. PubMed ID: 26208584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor.
    Choi YJ; Chakraborty S; Nguyen V; Nguyen C; Kim BK; Shim SI; Suki WN; Truong LD
    Hum Pathol; 2000 Dec; 31(12):1491-7. PubMed ID: 11150374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capillary rarefaction: a missing link in renal and cardiovascular disease?
    Steegh FMEG; Keijbeck AA; de Hoogt PA; Rademakers T; Houben AJHM; Reesink KD; Stehouwer CDA; Daemen MJAP; Peutz-Kootstra CJ
    Angiogenesis; 2024 Feb; 27(1):23-35. PubMed ID: 37326760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spironolactone suppresses peritubular capillary loss and prevents deoxycorticosterone acetate/salt-induced tubulointerstitial fibrosis.
    Iwazu Y; Muto S; Fujisawa G; Nakazawa E; Okada K; Ishibashi S; Kusano E
    Hypertension; 2008 Mar; 51(3):749-54. PubMed ID: 18250361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Renal Hypoxia in the Progression From Acute Kidney Injury to Chronic Kidney Disease.
    Ullah MM; Basile DP
    Semin Nephrol; 2019 Nov; 39(6):567-580. PubMed ID: 31836039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritubular capillary regression during the progression of experimental obstructive nephropathy.
    Ohashi R; Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    J Am Soc Nephrol; 2002 Jul; 13(7):1795-805. PubMed ID: 12089375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regardless of etiology, progressive renal disease causes ultrastructural and functional alterations of peritubular capillaries.
    Bábíčková J; Klinkhammer BM; Buhl EM; Djudjaj S; Hoss M; Heymann F; Tacke F; Floege J; Becker JU; Boor P
    Kidney Int; 2017 Jan; 91(1):70-85. PubMed ID: 27678159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury.
    Kida Y; Ieronimakis N; Schrimpf C; Reyes M; Duffield JS
    J Am Soc Nephrol; 2013 Mar; 24(4):559-72. PubMed ID: 23492730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Capillary rarefaction is more closely associated with CKD progression after cisplatin, rhabdomyolysis, and ischemia-reperfusion-induced AKI than renal fibrosis.
    Menshikh A; Scarfe L; Delgado R; Finney C; Zhu Y; Yang H; de Caestecker MP
    Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1383-F1397. PubMed ID: 31509009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gli1
    Kramann R; Wongboonsin J; Chang-Panesso M; Machado FG; Humphreys BD
    J Am Soc Nephrol; 2017 Mar; 28(3):776-784. PubMed ID: 27624490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation, and fibrosis.
    Liu S; Soong Y; Seshan SV; Szeto HH
    Am J Physiol Renal Physiol; 2014 May; 306(9):F970-80. PubMed ID: 24553434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal resistive index correlates with peritubular capillary loss and arteriosclerosis in biopsy tissues from patients with chronic kidney disease.
    Kimura N; Kimura H; Takahashi N; Hamada T; Maegawa H; Mori M; Imamura Y; Kusaka Y; Yoshida H; Iwano M
    Clin Exp Nephrol; 2015 Dec; 19(6):1114-9. PubMed ID: 26081566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.
    Kang DH; Anderson S; Kim YG; Mazzalli M; Suga S; Jefferson JA; Gordon KL; Oyama TT; Hughes J; Hugo C; Kerjaschki D; Schreiner GF; Johnson RJ
    Am J Kidney Dis; 2001 Mar; 37(3):601-11. PubMed ID: 11228186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Schellinger IN; Cordasic N; Panesar J; Buchholz B; Jacobi J; Hartner A; Klanke B; Jakubiczka-Smorag J; Burzlaff N; Heinze E; Warnecke C; Raaz U; Willam C; Tsao PS; Eckardt KU; Amann K; Hilgers KF
    Kidney Int; 2017 Mar; 91(3):616-627. PubMed ID: 27927598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells.
    Cantaluppi V; Gatti S; Medica D; Figliolini F; Bruno S; Deregibus MC; Sordi A; Biancone L; Tetta C; Camussi G
    Kidney Int; 2012 Aug; 82(4):412-27. PubMed ID: 22495296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caspase-3 Is a Pivotal Regulator of Microvascular Rarefaction and Renal Fibrosis after Ischemia-Reperfusion Injury.
    Yang B; Lan S; Dieudé M; Sabo-Vatasescu JP; Karakeussian-Rimbaud A; Turgeon J; Qi S; Gunaratnam L; Patey N; Hébert MJ
    J Am Soc Nephrol; 2018 Jul; 29(7):1900-1916. PubMed ID: 29925521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.